TWE:ASXTreasury Wine Estates Limited Analysis
Data as of 2026-03-15 - not real-time
A$3.94
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Treasury Wine Estates (TWE.AX) is trading at AUD 3.94, well below its 20‑day (AUD 4.46) and 50‑day (AUD 4.97) simple moving averages, signaling a sustained bearish price trend. The RSI of 26 indicates the stock is oversold, while a bearish MACD histogram reinforces short‑term downside pressure. Fundamentally, the company is struggling: revenue fell 16.6%, operating margins are deeply negative (‑55%), and the trailing EPS is –0.54, although forward EPS shows a modest improvement to 0.34. Cash flow remains a mixed picture with positive operating cash flow (AUD 382 M) but negative free cash flow (‑AUD 59.8 M) and a heavy debt load of AUD 2.08 B versus only AUD 0.22 B in cash. The dividend yield appears attractive at 8.8%, but the payout ratio of 72% on a loss‑making base raises questions about sustainability. A discounted cash‑flow model values the shares at roughly AUD 2.20, implying the current price is overvalued relative to intrinsic estimates, yet analyst targets (mean AUD 5.61) suggest upside potential if a turnaround materialises.
Given the high 30‑day volatility (≈50%), low beta (0.54), and decreasing volume, the stock carries elevated market risk, while its consumer‑defensive positioning tempers sector risk. Regulatory and geographic exposures are moderate due to alcohol‑related oversight and operations across Australia, the U.S., and Europe. Overall, TWE presents a classic value‑oriented, high‑yield play that is currently out‑of‑step with its fundamentals, making it a cautious hold pending clearer earnings recovery.
Given the high 30‑day volatility (≈50%), low beta (0.54), and decreasing volume, the stock carries elevated market risk, while its consumer‑defensive positioning tempers sector risk. Regulatory and geographic exposures are moderate due to alcohol‑related oversight and operations across Australia, the U.S., and Europe. Overall, TWE presents a classic value‑oriented, high‑yield play that is currently out‑of‑step with its fundamentals, making it a cautious hold pending clearer earnings recovery.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Price below key moving averages (20‑day and 50‑day)
- Bearish MACD and oversold RSI
- Heavy debt load versus limited cash
Medium Term
1–3 yearsNeutral
Model confidence: 6/10
Key Factors
- Potential earnings improvement (forward EPS positive)
- Strong dividend yield but sustainability concerns
- Operating cash flow remains positive
Long Term
> 3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF fair value suggests significant downside upside if turnaround succeeds
- Consumer‑defensive sector provides a defensive moat
- Analyst price targets indicate upside potential
Key Metrics & Analysis
Financial Health
Revenue Growth-16.60%
Profit Margin-15.88%
P/E Ratio11.6
ROE-9.91%
ROA-2.91%
Debt/Equity53.69
P/B Ratio0.8
Op. Cash FlowA$382.3M
Free Cash FlowA$-59775000
Technical Analysis
TrendBearish
RSI26.1
SupportA$3.92
ResistanceA$5.39
MA 20A$4.46
MA 50A$4.97
MA 200A$6.49
MACDBearish
VolumeDecreasing
Fear & Greed Index72.88
Valuation
Fair ValueA$2.20
Target PriceA$5.61
Upside/Downside42.44%
GradeOvervalued
TypeValue
Dividend Yield8.81%
Risk Assessment
Beta0.54
Volatility49.67%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.